Skip to Content

Inogen Inc INGN

Morningstar Rating
$8.07 +0.11 (1.32%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INGN is trading at a 50% discount.
Price
$7.47
Fair Value
$92.24
Uncertainty
Extreme
1-Star Price
$24.16
5-Star Price
$7.16
Economic Moat
Pfw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INGN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$7.97
Day Range
$7.908.19
52-Week Range
$4.1314.10
Bid/Ask
$8.04 / $8.05
Market Cap
$188.25 Mil
Volume/Avg
315,844 / 623,472

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.59
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
834

Comparables

Valuation

Metric
INGN
MMSI
SIBN
Price/Earnings (Normalized)
25.17
Price/Book Value
0.903.653.93
Price/Sales
0.593.524.53
Price/Cash Flow
20.54
Price/Earnings
INGN
MMSI
SIBN

Financial Strength

Metric
INGN
MMSI
SIBN
Quick Ratio
2.363.818.01
Current Ratio
2.865.459.01
Interest Coverage
8.07−13.52
Quick Ratio
INGN
MMSI
SIBN

Profitability

Metric
INGN
MMSI
SIBN
Return on Assets (Normalized)
−13.15%9.43%−8.97%
Return on Equity (Normalized)
−18.72%14.77%−12.61%
Return on Invested Capital (Normalized)
−19.07%11.47%−11.78%
Return on Assets
INGN
MMSI
SIBN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesBfsqfqmCgsyvt$197.2 Bil
SYK
Stryker CorpZwbjdnrzrYrqz$136.2 Bil
MDT
Medtronic PLCVkhwkffdMrmbngr$115.7 Bil
BSX
Boston Scientific CorpTbjpljdqXrvnft$100.7 Bil
EW
Edwards Lifesciences CorpRjftcfpgmHmrnpj$57.5 Bil
DXCM
DexCom IncZfmffnhspRvfl$53.5 Bil
ZBH
Zimmer Biomet Holdings IncZqcbmhdtdYkdv$27.1 Bil
ALGN
Align Technology IncBzjqtlntBxwwp$24.6 Bil
PHG
Koninklijke Philips NV ADRJjpznvjLjpgst$18.2 Bil
PODD
Insulet CorpBpzxycvxdVfwbzn$12.0 Bil

Sponsor Center